NASDAQ · TER
Teradyne, Inc.
$296.23-$17.01 (-5.43%)
Teradyne, Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.29% below the high.
Loading market information…
AMEX · INTT · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
inTEST Corporation’s quoted price sits in the upper half of its reported 52-week range, 21.05% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
inTEST Corporation’s next earnings report is currently expected on Nov 6, 2026, with estimated earnings per share of $0.11. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow inTEST Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
inTEST Corporation is a global provider of specialized equipment and services for manufacturing and testing processes across various industries, including automotive, defense/aerospace, industrial, life sciences, security, and semiconductor sectors. The company operates through two main divisions: Thermal Products and Electromechanical Semiconductor Products (EMS). The Thermal Products segment delivers a range of environmental and thermal management solutions. This includes ThermoStream products, which function as standalone temperature control units or integrate into diverse electronic test setups. The segment also offers Thermal Chambers, Thermal Platforms, and Thermonics temperature conditioning units designed to provide precisely tempered gas or fluid. Additionally, it supplies specialized cryogenic storage solutions, such as biomedical freezers, refrigerators, and mobile storage, alongside EKOHEAT and EASYHEAT induction heating systems, and digital streaming and image acquisition technologies. The Electromechanical Semiconductor Products (EMS) segment focuses on high-precision equipment for semiconductor testing. It produces manipulators (including the in2, Cobal, and LS series) that securely hold and allow operators to accurately reposition test heads for compatibility with various probers or handlers on a test floor. This segment also manufactures crucial docking hardware to protect interface contacts and ensure consistent, precise alignment between the test head's interface board and the prober's or handler's probing assembly. Furthermore, EMS offers tester interfaces that establish vital electrical connections between the primary test unit and wafer probers or integrated circuit (IC) handlers. Its portfolio extends to Scorpion flying probe test systems, which are robotic electronic testing platforms, complemented by comprehensive application support services. These EMS solutions are primarily employed by semiconductor manufacturers for the back-end production testing of both wafers and specialized packaged integrated circuits. inTEST Corporation distributes its products to a broad clientele within the semiconductor ecosystem, including direct semiconductor manufacturers, third-party foundries, independent test and assembly providers, and original equipment manufacturers (OEMs). Established in 1981, inTEST Corporation's headquarters are located in Mount Laurel, New Jersey.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 29, 2026, 11:42 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 2, 2025 | -$0.11-37.5% vs estimate | $26.64M-14.94% vs estimate |
|---|
| Q4 2024 | Mar 7, 2025 | $0.23+64.29% vs estimate | $36.60M+15.83% vs estimate |
|---|
| Q3 2024 | Nov 1, 2024 | $0.10+42.86% vs estimate | $30.27M-14.32% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $17.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$296.23-$17.01 (-5.43%)
Teradyne, Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.29% below the high.
$126.67-$2.11 (-1.64%)
Camtek Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.35% below the high.
$79.68+$0.24 (+0.3%)
Kulicke and Soffa Industries, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.33% below the high.
$112.02-$1.71 (-1.5%)
Axcelis Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.19% below the high.
$42.80-$1.04 (-2.37%)
Veeco Instruments Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.59% below the high.
$53.40+$0.26 (+0.49%)
Cohu, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.48% below the high.
$54.70-$1.18 (-2.11%)
Ultra Clean Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.07% below the high.
$61.21-$3.33 (-5.16%)
Aehr Test Systems’s quoted price sits in the lower half of its reported 52-week range, 58.47% below the high.
